European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- 1-[2-(Benzo[1,2,5]thiadiazol-5-ylamino)-6-(2,6-dichloro-phen
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
1-[2-(Benzo[1,2,5]thiadiazol-5-ylamino)-6-(2,6-dichloro-phenyl)-pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butyl-urea
| EU orphan designation number: | EU/3/10/770
|
| Active ingredient: | 1-[2-(Benzo[1,2,5]thiadiazol-5-ylamino)-6-(2,6-dichloro-phenyl)-pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butyl-urea |
| Indication: | Treatment of acute myeloid leukaemia |
| Sponsor: | Sanofi-Aventis groupe
54 rue La Boétie, F-75008 Paris, France |
Public summary of scientific opinion
